Morgan Stanley Maintains Overweight on P10, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Michael Cyprys has maintained an Overweight rating on P10 but has reduced the price target from $13 to $12.
January 24, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has maintained an Overweight rating on P10 but lowered the price target from $13 to $12, indicating a positive outlook with a slightly reduced growth expectation.
While the Overweight rating suggests that Morgan Stanley's outlook on P10 remains positive, the reduction in the price target could imply a tempered expectation for the stock's growth potential in the short term. This could lead to a neutral short-term impact as the market digests the news, balancing the maintained positive rating with the lowered price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100